Topics

Immunis.AI Company Profile

23:17 EST 22nd January 2020 | BioPortfolio

Immunis.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology, for a truly individualized assessment. Our Intelligentia platform combines the power of the immune defense system, RNAseq technology and machine learning for the development of proprietary disease-specific algorithms. Our approach compares the differential gene expression patterns from two immune cells, using the patient as the control, normalizing and enhancing the signal of the underlying pathology. Intelligentia is a disruptive alternative, leveraging the immune system’s surveillance apparatus to overcome the limitations of cfDNA and CTC’s, enabling us to improve early stage disease detection, at the point of immune-escape, when there is the best opportunity for cure. For more information, please visit: immunis.ai


News Articles [1 Associated News Articles listed on BioPortfolio]

OncoCell MDx, Now Immunis.AI, to Present at Biotech Showcase

OncoCell MDx, a privately held immunogenomics company with a patented liquid biopsy platform, today announced it has changed its name to Immunis.AI. The name was chosen to better reflect the power an...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Mushroom bodies in Reptantia reflect a major transition in crustacean brain evolution.

Brain centers possessing a suite of neuroanatomical characters that define mushroom bodies of dicondylic insects have been identified in mantis shrimps, which are basal malacostracan crustaceans. Rece...

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Immunis.AI

Immunis.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology, for a truly individualized assessment. Our Intelligentia...

More Information about "Immunis.AI" on BioPortfolio

We have published hundreds of Immunis.AI news stories on BioPortfolio along with dozens of Immunis.AI Clinical Trials and PubMed Articles about Immunis.AI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immunis.AI Companies in our database. You can also find out about relevant Immunis.AI Drugs and Medications on this site too.

Quick Search

Relevant Topic

Gene Expression
The process of gene expression is used by eukaryotes, prokaryotes, and viruses to generate the macromolecular machinery for life. Steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-tran...


Corporate Database Quicklinks



Searches Linking to this Company Record